Have a personal or library account? Click to login
Optimal final adult height achieved by low-dose recombinant human growth hormone therapy Cover

Optimal final adult height achieved by low-dose recombinant human growth hormone therapy

Asian Biomedicine
Volume 18 (2024): Issue 2 (April 2024)
By: Tansit Saengkaew,  Suparb Aroonparkmongkol and  Suttipong Wacharasindhu  
Open Access
|Apr 2024

Authors

Tansit Saengkaew

Division of Endocrinology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand
Endocrinology Unit, Department of Pediatrics, Faculty of Medicine, Prince of Songkla University, Songkhla, Thailand

Suparb Aroonparkmongkol

Division of Endocrinology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand

Suttipong Wacharasindhu

Suttipong.W@chula.ac.th

Division of Endocrinology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand
DOI: https://doi.org/10.2478/abm-2024-0011 | Journal eISSN: 1875-855X | Journal ISSN: 1905-7415
Journal RSS Feed
Language: English
Page range: 53 - 60
Published on: Apr 30, 2024
Published by: Chulalongkorn University
In partnership with: Paradigm Publishing Services
Publication frequency: 6 issues per year
Keywords:
growth hormone,
growth hormone deficiency,
growth hormone treatment,
recombinant human growth hormone,
short stature
Related subjects:
Medicine,
Assistive professions, nursing,
Basic medical science,
Basic medical science, other,
Clinical medicine,
Clinical medicine, other

© 2024 Tansit Saengkaew, Suparb Aroonparkmongkol, Suttipong Wacharasindhu, published by Chulalongkorn University
This work is licensed under the Creative Commons Attribution 4.0 License.

Previous articleVolume 18 (2024): Issue 2 (April 2024)Next article